Announce Date | 01/22/2025 |
EPS Normalized Actual | $0.55 (Beat by $0.05) |
EPS GAAP Actual | $0.55 (Beat by $0.05) |
Revenue Actual | $4.3179B |
Revenue Surprise | Beat by $4317.9M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.8975 |
EPS GAAP Estimate | $0.8975 |
Revenue Estimate | $3.487903715B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.26569 | 11.23 | 5.01562 | 5.58952 | 2 |
Dec 2026 | 4.09238 | 14.44 | 3.6 | 4.69864 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 4.3179B | 22.94% | 4317.9M |
FQ3 2024 (Sep 2024) | 1.19 | 1.19 | 4.0389B | 20.79% | 4038.9M |
FQ2 2024 (Jun 2024) | 0.44 | 0.44 | 3.6097B | 15.4% | 3609.7M |
FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 3.2563B | 8.67% | 3256.3M |
FQ4 2023 (Dec 2023) | 0.86 | 0.86 | 3.3275B | 2.66% | 3327.5M |
FQ3 2023 (Sep 2023) | 0.86 | 0.86 | 3.1992B | -3% | 3199.2M |
FQ2 2023 (Jun 2023) | 0.77 | 0.77 | 3.0539B | -2.71% | 3053.9M |
FQ1 2023 (Mar 2023) | 0.74 | 0.74 | 2.974B | 100% | 2974M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.8975
Consensus Revenue Estimates
3.487903715B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.7101 | -- | 0.68866 | 0.74112 | 2 |
FQ2 2027 (Jun 2027) | 0.6693 | -- | 0.64909 | 0.69854 | 2 |
FQ1 2027 (Mar 2027) | 0.63392 | -- | 0.60315 | 0.66835 | 2 |
FQ4 2026 (Oct 2026) | 1.0831 | -- | 1.05288 | 1.11124 | 3 |
FQ3 2026 (Jul 2026) | 1.0031 | -- | 0.97511 | 1.02916 | 3 |
FQ2 2026 (Jun 2026) | 0.54491 | -- | 0.52322 | 0.5608 | 4 |
FQ1 2026 (Mar 2026) | 0.51739 | -- | 0.4968 | 0.53247 | 4 |
FQ4 2025 (Oct 2025) | 0.98 | 36.73 | 0.95266 | 1.00546 | 4 |
FQ3 2025 (Jul 2025) | 0.914 | -30.2 | 0.8885 | 0.93775 | 4 |
FQ2 2025 (Jun 2025) | 0.8975 | 50.97 | 0.87769 | 0.92352 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 5.2B | -- | 5.08B | 5.37B | 3 |
FQ2 2027 (Jun 2027) | 4.94B | -- | 4.83B | 5.11B | 3 |
FQ1 2027 (Mar 2027) | 4.79B | -- | 4.61B | 4.99B | 3 |
FQ4 2026 (Oct 2026) | 4.02B | -- | 3.93B | 4.1B | 4 |
FQ3 2026 (Jul 2026) | 3.81B | -- | 3.73B | 3.88B | 4 |
FQ2 2026 (Jun 2026) | 4.21B | -- | 4.09B | 4.31B | 3 |
FQ1 2026 (Mar 2026) | 4.02B | -- | 3.9B | 4.11B | 3 |
FQ4 2025 (Oct 2025) | 3.73B | -15.65 | 3.65B | 3.81B | 3 |
FQ3 2025 (Jul 2025) | 3.54B | -13.98 | 3.47B | 3.61B | 3 |
FQ2 2025 (Jun 2025) | 3.49B | -3.49 | 3.43B | 3.57B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 100% | |
FQ3 2024 (Sep 2024) | 1.19 | 1.19 | 100% | |
FQ2 2024 (Jun 2024) | 0.44 | 0.44 | 100% | |
FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 100% | |
FQ4 2023 (Dec 2023) | 0.86 | 0.86 | 100% | |
FQ3 2023 (Sep 2023) | 0.86 | 0.86 | 100% | |
FQ2 2023 (Jun 2023) | 0.77 | 0.77 | 100% | |
FQ1 2023 (Mar 2023) | 0.74 | 0.74 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $4.32B | $4317.9M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.04B | $4038.9M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.61B | $3609.7M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.26B | $3256.3M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.33B | $3327.5M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.2B | $3199.2M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.05B | $3053.9M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2.97B | $2974M | 100% |